Histone deacetylase inhibitors

Details for Australian Patent Application No. 2005274973 (hide)

Owner Aton Pharma, Inc.

Inventors Miller, Thomas A.; Belvedere, Sandro; Witter, David J.

Agent Spruson & Ferguson

Pub. Number AU-A-2005274973

PCT Pub. Number WO2006/020004

Priority 60/589,079 19.07.04 US

Filing date 15 July 2005

Wipo publication date 23 February 2006

International Classifications

A61K 31/185 (2006.01) - Acids

A61K 31/19 (2006.01)

C07C 259/04 (2006.01) Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/020004 Priority application(s): WO2006/020004

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274974-Salivary transcriptome diagnostics

2005274972-Ophthalmic compositions for treating ocular hypertension